|Particulars||Sep-20 Quarter||Growth (yoy)||Growth (qoq)|
|Key Ratios||Sep-20 Quarter||Sep-19 Quarter||Jun-20 Quarter|
|Net Profit Margin||10.12%||9.73%||9.08%|
Key takeaways from the Sep-20 quarter results
- Net cash generated from operating activities in the first half of the fiscal year was up more than 7-fold at Rs239cr on the back of more favourable working capital movements in the first half of this fiscal as compared to last year.
- In terms of segmental verticals, technology and emerging verticals accounted for over 45% of the total revenues while BFSI accounted for about 30% with healthcare and life sciences accounting for the balance in the Sep-20 quarter.
- The company has recently received a show cause notice from the Department of Revenue Intelligence (DRI) pertaining to export incentives of Rs25.55cr claimed by the company. While no provision is made, the impact is likely to be minimal.